0000950103-24-011229.txt : 20240730
0000950103-24-011229.hdr.sgml : 20240730
20240730210155
ACCESSION NUMBER: 0000950103-24-011229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240726
FILED AS OF DATE: 20240730
DATE AS OF CHANGE: 20240730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Venker Eric
CENTRAL INDEX KEY: 0001801917
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 241159590
MAIL ADDRESS:
STREET 1: C/O ROIVANT SCIENCES, INC.
STREET 2: 320 WEST 37TH STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
dp2015709_4-venker.xml
FORM 4
X0508
4
2024-07-26
0
0001635088
Roivant Sciences Ltd.
ROIV
0001801917
Venker Eric
C/O ROIVANT SCIENCES LTD.
7TH FLOOR, 50 BROADWAY
LONDON
X0
SW1H 0DB
UNITED KINGDOM
0
1
0
0
President & COO
0
Common Shares
2024-07-26
4
A
0
204000
0
A
650307
D
Stock Option (Right to Buy)
10.80
2024-07-26
4
A
0
409000
0
A
2034-07-25
Common Shares
409000
409000
D
Reflects an award of restricted stock units with respect to Common Shares, with a vesting commencement date of April 20, 2024, which service-vest (i) 25% on May 20, 2025 and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date.
Reflects an award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
2024-07-30